Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
A Previously Unattested Egyptian Title and a Face from Roman Egypt: TimeLine’s 8 September Auction
-
The companies of CSG group will showcase their products at MSPO 2026, the largest trade fair of its kind in Central Europe
-
Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company
-
Kane Biotech Expands Canadian Commercial Reach with Ontario Medical Supply Inc.
-
uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease
-
Charles IT Expands AI and Automation Capabilities Through Acquisition of Descent
-
Teva Announces Positive Topline Results from Phase 2a Study in Celiac Disease for Its Anti-IL-15 Antibody, Further Validating Its Pipeline-in-a-Product Potential
-
Taco Cabana Turns 48 With a Monthlong Celebration
-
Cardiff Oncology to Participate in September 2026 Conferences
-
MoneySimpler Unveils AI Automated Stock & Forex Trading to Boost Income for Social Security Benefits
-
G-III Apparel Group, Ltd. Reports Second Quarter Fiscal 2027 Results and Raises Earnings Guidance
-
Wallbridge Reports Results from 2026 Fenelon PFS Metallurgical Drilling Program
-
EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting
-
Newron announces completion of screening for enrollment in pivotal Phase 3 ENIGMA-TRS 1 study with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
-
Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September
-
Tonix Pharmaceuticals to Participate in Cantor’s 2026 Global Healthcare Conference
-
Opus Genetics to Present OPGx-BEST1 Cohort 1 Clinical Data in Investor Webcast and at Upcoming Leading Ophthalmology Conferences
-
Can-Fite Reports Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study
-
TScan Therapeutics Announces Strategic Reorganization to Focus on in vivo Cell Therapy for Solid Tumors
-
9/11 and Immigration Panel: 25 Years of Lessons and Unfinished Business
-
MediWound to Present at the H.C. Wainwright 28th Annual Global Investment Conference
-
WRAP Moves to Operationalize De-Escalation, Advances New BolaWrap 150 Doctrine Toward California POST Certification
-
By Popular Demand: Tilray Beverages Makes Popsicle Hard Firecracker a Permanent Flavor
-
G-III Apparel Group, Ltd. Reports Second Quarter Fiscal 2027 Results and Raises Earnings Guidance
-
Fortrea to Acquire Clinical Pharmacology Unit and Bioanalytical Laboratory Operations from Worldwide Clinical Trials
-
GoldInxs Announces Completion of Field Program at Millar Property in British Columbia’s Golden Triangle
-
Ollie’s Bargain Outlet Holdings, Inc. Announces Second Quarter Fiscal 2026 Results
-
GXO Announces Participation in Upcoming Investor Conferences
-
Axsome Therapeutics to Participate in Upcoming Investor Conferences
-
Verano Announces Upcoming Conference Participation
-
European Wax Center Releases Limited Edition Golden Orchard Body Butter and Body Polish for Post-Wax Skincare
-
Climb Bio to Present at Upcoming Investor Conferences
-
Zentek Ltd. Begins Trading on OTCQX Best Market
-
Maze Therapeutics to Participate in Three Upcoming Investor Conferences
-
Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences
-
Aeluma to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on September 16, 2026
-
Rapport Therapeutics to Participate in Upcoming Investor Conferences
-
FactSet Schedules Fourth Quarter 2026 Earnings Call
-
Sitryx to Participate in Upcoming Investor Conferences
-
VEON to Release 3Q26 Earnings on November 6, 2026, Capital Markets Day Scheduled for November 16, 2026
-
CoinShares Completes Acquisition of Bastion Asset Management
-
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
-
Solera Launches Sales Radar Inside CRM by Solera (DealerSocket), Turning Revenue Radar Equity Signals Into Automated, Hyper-Targeted Omnichannel Marketing Campaigns
-
Wolverine Stack: Kylo Peptides Introduces New BPC-157 and TB-500 Research Combination
-
Reliance, Inc. Announces Participation at the 2026 Jefferies Global Industrials Conference
-
Major Shareholder Announcement
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SEGRO PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - ROTORK PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - PROLOGIS INC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - MITIE GROUP PLC - Ordinary Shares
